Modeling and Comparative Effectiveness
  
|
"Comparative effectiveness research (CER) is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, or to improve the delivery of care."
- National Institute of Medicine "Comparative Effectiveness Research" 2009. |
It has often been said that Comparative Effectiveness Research (CER) is not new – but the emphasis on CER unquestionably is. Pharmacoeconomic Modeling also plays a key role. Your US and Global customers want to know how your drug, diagnostic test, or medical device stacks up against alternatives. Having data (from clinical trials or from modeling) is essential to show the value of your brand
SPI works closely with leading healthcare economists to find modeling and CER approaches that can work best for you.
Give us a call!
The three references shown are highly recommended: H.C. Sox and S Greenfield, Co-Chairs, "Comparative Effectiveness Research" Institute of Medicine, National Academies Press, Washington DC, 2009; M.F. Drummond et al "Methods for the Evaluation of Health Care Programmes," Third Edition, Oxford University Press, Oxford, England 2005; J. Eden et al, Editors, "Finding What Works in Health Care" Institute of Medicine, National Academies Press, Washington DC, 2011.
|
(206) 369-7921